Name: UMIN ID:
Unique ID issued by UMIN | UMIN000010666 |
---|---|
Receipt number | R000012475 |
Scientific Title | Examination of change about comprehensive functional assessment before and while chemotherapy for pancreatic cancer in elderly patients using Cancer-Specific Geriatric Assessment(CSGA) |
Date of disclosure of the study information | 2013/05/08 |
Last modified on | 2021/05/14 19:36:13 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2013/05/08 12:42:14 | ||
2 | Update | 2014/05/08 17:48:59 | Recruitment status Other related information Other related information |
|
3 | Update | 2014/05/08 17:50:41 | Target sample size |
|
4 | Update | 2015/05/08 16:35:15 | Email |
|
5 | Update | 2016/03/24 18:49:49 | Last name of contact person Last name of contact person Division name |
|
6 | Update | 2016/05/09 17:00:53 | Last follow-up date Publication of results |
|
7 | Update | 2016/08/23 13:06:33 | Recruitment status Last follow-up date Results Results |
|
8 | Update | 2016/11/24 18:14:19 | Name of primary person or sponsor Institute Institute Department Organization Category of Funding Organization Organization1 Tel1 Email1 Institutions |
|
9 | Update | 2016/11/24 18:16:20 | Organization Category of Funding Organization Institutions |
|
10 | Update | 2016/11/24 18:24:48 | TEL |
|
11 | Update | 2017/11/11 15:49:53 | Last follow-up date Date of closure to data entry |
|
12 | Update | 2018/05/14 21:13:02 | Recruitment status Date trial data considered complete Date analysis concluded |
|
13 | Update | 2018/08/27 18:13:50 | Recruitment status |
|
14 | Update | 2018/08/27 18:14:42 | Date trial data considered complete Date analysis concluded |
|
15 | Update | 2018/11/11 19:29:08 | Institutions |
|
16 | Update | 2020/05/15 18:58:37 | Publication of results Number of participants that the trial has enrolled Results Results Results date posted Results Delayed Results Delay Reason Results Delay Reason Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
17 | Update | 2021/05/14 19:34:57 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Division name Zip code Name of primary person or sponsor Co-sponsor Co-sponsor Organization Organization Address Address Tel |
|
18 | Update | 2021/05/14 19:36:13 | Recruitment status Date of IRB |